ADVANCED NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets resistant lung cancer in early trial
Disease control Not yet recruitingThis early-phase trial tests whether adding capivasertib to osimertinib can help people with a specific type of advanced lung cancer (EGFR-mutant NSCLC) that has stopped responding to first-line osimertinib. About 53 adults with certain genetic changes (PIK3CA/AKT1/PTEN) will rec…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanxi Province Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 11:48 UTC
-
Blood test may predict lung cancer treatment success
Knowledge-focused Not yet recruitingThis study aims to find out if changes in specific immune cells in the blood can predict how well chemoimmunotherapy works in people with advanced non-small cell lung cancer. Researchers will collect blood samples from 80 participants before and after two treatment cycles. The go…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC